Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma

• WITZIG TE

収録刊行物

• J Clin Oncol.

  J Clin Oncol. 17 3793-3803, 1999

詳細情報

• CRID: 1571980075510456576
• NII論文ID: 10021256828
• データソース種別:
  • CiNii Articles